Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.1.53 (
sialidase
)
2,694
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The mucin-type carbohydrate Tn cryptantigen (GalNAc alpha 1-O-Ser/Thr, where GalNAc is N-acetyl-D-galactosamine) is expressed in many carcinomas, in haemopoietic disorders including the Tn syndrome, and on human immunodeficiency virus (HIV) coat glycoproteins, but is not expressed on normal, differentiated cells because of the expression of a Tn-processing galactosyltransferase. Using Jurkat T leukaemic cells which express high levels of Tn antigen due to deficient Tn galactosylation, we have established the Tn antigen-mediated gene transfer and demonstrate the considerable efficiency of this approach. We used poly(L-lysine) conjugates of the monoclonal antibody 1E3 directed against the Tn antigen to deliver the luciferase and beta-galactosidase reporter genes to Jurkat cells by receptor-mediated endocytosis. Addition of unconjugated 1E3 reduced transfection efficiency in a concentration-dependent manner and incubation with free GalNAc abolished DNA transfer completely, indicating that gene delivery is indeed mediated by the Tn antigen. Pre-treatment of Jurkat cells with Vibrio cholerae
sialidase
, which uncovers additional Tn antigens, resulted in an improvement of gene transfection. Both human and chicken adenovirus particles attached to the DNA/polylysine complex strongly augmented transgene expression. When the beta-galactosidase (lacZ) gene was delivered to Jurkat cells by Tn-mediated endocytosis, up to 60% of the cells were positive in the cytochemical stain using 5-bromo-4-chloro-3-indolyl-beta-D-galactopyranoside (X-gal) as a chromogenic substrate. The efficiency of the
transferrin receptor
-mediated DNA uptake into Jurkat cells was comparatively low, although these cells were shown to express considerable amounts of
transferrin receptor
. We show here that a mucin-type carbohydrate antigen mediates highly efficient DNA uptake by endocytosis into Jurkat T cells. This method represents a 50-fold improvement of Jurkat cell transfection efficiency over other physical gene transfer techniques. Specific gene delivery to primary cancer cells exhibiting Tn epitopes may especially be desirable in immunotherapy protocols.
...
PMID:Carbohydrate receptor-mediated gene transfer to human T leukaemic cells. 782 4
Transferrin receptor
(
TfR
) has been identified as a candidate IgA1 receptor expressed on human mesangial cells (HMC).
TfR
binds IgA1 but not IgA2, co-localizes with mesangial IgA1 deposits, and is overexpressed in patients with IgA nephropathy (IgAN). Here, structural requirements of IgA1 for its interaction with mesangial
TfR
were analyzed. Polymeric but not monomeric IgA1 interacted with
TfR
on cultured HMC and mediates internalization. IgA1 binding was significantly inhibited (>50%) by soluble forms of both TfR1 and TfR2, confirming that
TfR
serves as mesangial IgA1 receptor. Hypogalactosylated serum IgA1 from patients with IgAN bound
TfR
more efficiently than IgA1 from healthy individuals. Serum IgA immune complexes from patients with IgAN containing aberrantly glycosylated IgA1 bound more avidly to
TfR
than those from normal individuals. This binding was significantly inhibited by soluble
TfR
, highlighting the role of
TfR
in mesangial IgA1 deposition. For addressing the potential role of glycosylation sites in IgA1-
TfR
interaction, a variety of recombinant dimeric IgA1 molecules were used in binding studies on
TfR
with Daudi cells that express only
TfR
as IgA receptor. Deletion of either N- or O-linked glycosylation sites abrogated IgA1 binding to
TfR
, suggesting that sugars are essential for IgA1 binding. However,
sialidase
and beta-galactosidase treatment of IgA1 significantly enhanced IgA1/
TfR
interaction. These results indicate that aberrant glycosylation of IgA1 as well as immune complex formation constitute essential factors favoring mesangial
TfR
-IgA1 interaction as initial steps in IgAN pathogenesis.
...
PMID:Glycosylation and size of IgA1 are essential for interaction with mesangial transferrin receptor in IgA nephropathy. 1497 64